Acute eczema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Concurrently meet the diagnostic criteria of Western medicine and the criteria of damp-heat syndrome in Traditional Chinese Medicine; (2) Age between 18 and 70 years, with no restriction on gender; (3) No history of receiving glucocorticoids, antihistamines, immunosuppressants, or traditional Chinese medicine related to the treatment of acute eczema within the past 2 weeks prior to enrollment; (4) Patients and their families are fully informed about the content of this study, voluntarily sign the informed consent form, and are able to cooperate to complete the treatment and follow-up.
Exclusion criteria
Exclusion criteria: (1) Patients with other skin diseases, such as seborrheic dermatitis, psoriasis, neurodermatitis, or malignant skin tumors, which may affect the assessment of treatment efficacy; (2) Patients with an eczema area and severity index score =23 points, classified as severe acute eczema; (3) Patients with dysfunction of major organs such as heart, liver, kidney, or brain, or with underlying conditions such as autoimmune diseases, hematological disorders, or active infections; (4) Pregnant or breastfeeding women; (5) Patients with a clear history of allergy to the drugs used in this study (boric acid solution, hydrochloride cetirizine tablets, and the components of the Ephedra Forsythia Red Bean Decoction); (6) Patients with mental disorders, consciousness disorders, or cognitive dysfunction, who are unable to cooperate with symptom assessment and treatment; (7) Patients currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Score;eczema area and severity index Scoring;Visual Analog Scale;Proportion of nighttime itching duration.;inflammatory factor;Adverse Reaction; | — |
Countries
China
Contacts
Shiyan People's Hospital